These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19557456)

  • 41. Current strategies to prevent transmission of prions by human plasma derivatives.
    Burnouf T; Padilla A
    Transfus Clin Biol; 2006 Nov; 13(5):320-8. PubMed ID: 17254822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases.
    Puopolo M; Ladogana A; Vetrugno V; Pocchiari M
    Transfusion; 2011 Jul; 51(7):1556-66. PubMed ID: 21214582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross infection of Creutzfeldt-Jakob disease.
    Clarkson D
    Nurs Times; 2000 Feb 10-16; 96(6):43. PubMed ID: 11961750
    [No Abstract]   [Full Text] [Related]  

  • 44. Quality and risk management: the commitment of the Council of Europe.
    Bopp KF
    Transfus Clin Biol; 2001 Jun; 8(3):218-9. PubMed ID: 11499962
    [No Abstract]   [Full Text] [Related]  

  • 45. [BSE, prions, vCJD and (not only) homologous transfusion].
    Köhler M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):43-7. PubMed ID: 12522730
    [No Abstract]   [Full Text] [Related]  

  • 46. Exposure to Creutzfeldt-Jakob disease.
    Jt Comm Perspect; 2001 Aug; 21(8):10-1. PubMed ID: 11519345
    [No Abstract]   [Full Text] [Related]  

  • 47. [Variants of Creutzfeldt Jacob disease. Opinion of the Working Group on Blood of the Federal Ministry for Health and Social Security].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Sep; 48(9):1082-90. PubMed ID: 16160898
    [No Abstract]   [Full Text] [Related]  

  • 48. Transmission of BSE by blood transfusion.
    Sivakumaran M
    Lancet; 2000 Nov; 356(9243):1771-2. PubMed ID: 11095288
    [No Abstract]   [Full Text] [Related]  

  • 49. Transmission of BSE by blood transfusion.
    Holada K; Simák J; Vostal JG
    Lancet; 2000 Nov; 356(9243):1772. PubMed ID: 11095289
    [No Abstract]   [Full Text] [Related]  

  • 50. The impact of new-variant Creutzfeldt-Jakob disease on blood transfusion practice.
    Turner M
    Br J Haematol; 1999 Sep; 106(4):842-50. PubMed ID: 10519983
    [No Abstract]   [Full Text] [Related]  

  • 51. Prions and blood transfusion.
    Barbara J
    Transfus Sci; 2000; 22(1-2):49. PubMed ID: 10771380
    [No Abstract]   [Full Text] [Related]  

  • 52. Universal leucodepletion--practical and regulatory consequences.
    Barrowcliffe TW
    Transfus Sci; 1998 Dec; 19(4):361. PubMed ID: 10351156
    [No Abstract]   [Full Text] [Related]  

  • 53. MPs call for risk assessment review of safety of UK blood supply.
    O'Dowd A
    BMJ; 2014 Jul; 349():g4772. PubMed ID: 25059409
    [No Abstract]   [Full Text] [Related]  

  • 54. Blood recipients and CJD: to notify or not to notify, that is the question.
    Sibbald B
    CMAJ; 1998 Oct; 159(7):829-31. PubMed ID: 9805032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Legal obligation to inform the patient on the theoretical risk of CJD transmission by blood].
    Boixière A; Hergon E; Moutel G; Rouger P; Hervé C
    Transfus Clin Biol; 2004 Apr; 11(2):101-5. PubMed ID: 15120108
    [TBL] [Abstract][Full Text] [Related]  

  • 56. International views on universal leucodepletion: the perspective in Germany.
    Seitz MD
    Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
    [No Abstract]   [Full Text] [Related]  

  • 57. International views on universal leucodepletion: the perspective in Portugal.
    de Sousa G
    Transfus Sci; 1998 Dec; 19(4):351-2. PubMed ID: 10351152
    [No Abstract]   [Full Text] [Related]  

  • 58. Creutzfeldt-Jakob disease and transfusion safety: tilting at icebergs?
    Dodd RY; Sullivan MT
    Transfusion; 1998 Mar; 38(3):221-3. PubMed ID: 9563399
    [No Abstract]   [Full Text] [Related]  

  • 59. Operational and research approaches to universal leucodepletion in Scotland.
    Prowse C
    Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158
    [No Abstract]   [Full Text] [Related]  

  • 60. Perspective on Nordic views on selective/universal leukodepletion.
    Flesland O
    Transfus Sci; 1998 Dec; 19(4):355-7. PubMed ID: 10351154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.